期刊文献+

中西医结合治疗大鼠卡氏肺孢子菌肺炎的实验研究 被引量:4

Integrated traditional Chinese medicine and western medicine treating pneumocystis carinii pneumonia in rats model
下载PDF
导出
摘要 目的 探讨中药方剂和复方磺胺甲基异恶唑(SMZCO)针剂联合治疗卡氏肺孢子菌肺炎大鼠模型的疗效.方法 选用SD大鼠,设置正常对照组4只,利用地塞米松注射法,复制SD大鼠卡氏肺孢子菌肺炎模型并按随机数字法分为:卡氏肺孢子菌肺炎模型组9只,SMZCO治疗组9只,中药方剂治疗组9只,中药方剂联合SMZCO治疗组9只.酶联免疫分析法检测各组大鼠肺泡灌洗液中白细胞介素8(IL-8)、肿瘤坏死因子α(TNF-α)和血清乳酸脱氢酶(LDH)含量;六胺银染色观察肺组织印片肺孢子菌包囊,光镜和电镜观察肺组织病理学和超微结构变化.结果 5组间肺泡灌洗液的IL-8、TNF-α水平总体方差分别为8.97、10.23,P值为0.038、0.031,其总体差异有统计学意义.在治疗组中,中药方剂治疗组IL-8水平较高[(476±45) μg/L],中药方剂联合SMZCO治疗组最低[(302±18) μg/L],差异有统计学意义(P<0.05).5组间LDH水平总体差异有统计学意义(P =0.036).同SMZCO治疗组比较,中药方剂治疗组LDH水平[(184 ±56) U/L]较高,中药方剂联合SMZCO治疗组[(96±35) U/L]最低,差异有统计学意义(均P<0.05).SMZCO治疗组、中药方剂治疗组、中药方剂联合SMZCO治疗组的肺孢子菌包囊减少率分别为85.5%、15.2%和90.3%,差异有统计学意义(P<0.05).与SMZCO治疗组比较,中药方剂联合SMZCO治疗组肺间质炎性细胞浸润明显减少,肺泡及间隔修复基本完整,肺组织结构接近正常,肺孢子菌包囊明显减少.电镜观察模型组的肺组织可见肺泡上皮细胞变性脱落,基底膜暴露,间质胶原纤维增生,肺泡腔内蛋白渗出增多.肺孢子菌虫体与肺泡上皮细胞紧密接触.结论 中药方剂对卡氏肺孢子菌肺炎大鼠模型的虫体、炎性因子等有一定抑制作用,可改善肺泡上皮损伤,与SMZCO联合使用有较好疗效. Objective To investigate the therapeutic effect of integrated Chinese medicinal formulae with sulfamethoxazole (SMZCO) injection on pneumocystis carinii pneumonia (PCP) rat model.Methods The PCP Sprague-Dawley (SD) rat models were reproduced by the dexamethasone injection method,and the models were randomly divided into follow groups:normal control group (4 rats),group B (PCP model,9 rats),SMZCO treatment group(9 rats),Chinese medicinal formulae treatment group (9 rats),combination with Chinese medicinal formulae and SMZCO treatment group(9 rats).The concentrations of interleukin (IL)-8,tumor necrosis factor (TNF)-alpha in bronchoalveolar lavage fluid (BALF) and serum lactate dehydrogenase (LDH) were measured by enzyme-linked immunosorbent assay (ELISA).The Pneumocystis cysts were calculated by silver stain method.The pathology and ultrastructural changes were observed by light microscope after hematoxylin-eosin staining stain and electronic microscope.Results There were statistical significances of IL-8 and TNF-α concentrations in five groups.The F values were 8.97,10.23 respectively ; P values were 0.038,0.031 respectively.The IL-8 value in Chinese medicinal formulae treatment group(9 rats) was the highest (476 ±45) μg/L and the IL-8 value in group E was the lowest (302 ± 18) μg/L.There was a statistical significance of serum LDH concentration in the five groups (P =0.036).Compared with serum LDH value in Chinese medicinal formulae treatment group,the LDH value in Chinese medicinal formulae treatment group was the highest [(184 ± 56) U/L] ; the value in combination with Chinese medicinal formulae and SMZCO treatment group was the lowest [(96 ± 35) U/L].The differenceswere statistically significant (P 〈 0.05).The decrement rates among the treatment group were 85.5%,15.2% and 90.3% respectively,and the differences were statistically significant (P 〈 0.05).Compared with the pathological observation in Chinese medicinal
机构地区
出处 《中国医药》 2014年第2期168-172,共5页 China Medicine
基金 浙江省中医药普通课题(2007CA088)
关键词 卡氏肺孢子菌 卡氏肺孢子菌肺炎 复方磺胺甲基异恶唑 中药方剂 Pneumocystis carinii Pneumocystis carinii pneumonia Compound sulfamethoxazole Chinese medicinal formulae
  • 相关文献

参考文献15

二级参考文献80

共引文献72

同被引文献56

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部